TRACON Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration (wet AMD). The company's pipeline consists of product candidates such as TRC105, TRC102, TRC253, TRC694, and TRC205. The lead product TRC105 is an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or programmed cell death protein 1 pathway.
| Website: | www.traconpharma.com |
| Email: | mwiggins@traconpharma.com |
| Main Phone: | +1 858 550-0780 |
| Address: | 4350 La Jolla Village Drive |
| Address 2: | Suite 800 |
| State: | CA |
| City / Town: | San Diego |
| Country: | US |
| Postal Code: | 92122 |
| Exchange: | NSC |
| CEO: | Charles P. Theuer |
| Employees: | 19 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
TRACON Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration (wet AMD). The company's pipeline consists of product candidates such as TRC105, TRC102, TRC253, TRC694, and TRC205. The lead product TRC105 is an endoglin antibody, for the treatment of multiple solid tumor types in combination with inhibitors of the vascular endothelial growth factor pathway, or programmed cell death protein 1 pathway.
| Website: | www.traconpharma.com |
| Email: | mwiggins@traconpharma.com |
| Main Phone: | +1 858 550-0780 |
| Address: | 4350 La Jolla Village Drive |
| Address 2: | Suite 800 |
| State: | CA |
| City / Town: | San Diego |
| Country: | US |
| Postal Code: | 92122 |
| Exchange: | NSC |
| CEO: | Charles P. Theuer |
| Employees: | 19 |
| NAICS: | Medicinal and Botanical Manufacturing(325411) |
| Last Price 9.08 | Change $ -0.96 | Change % -9.56 | Tick N/A |
| Bid 9.11 | Bid Size 100.00 | Ask 9.15 | Ask Size 100.00 |
| Open 10.06 | High 10.40 | Low 8.90 | Prev Close 10.04 |
| Last Trade | Volume 1.2 mi | 52 Wk Hi 10.65 | 52 Wk Low 0.95 |
| Market Cap 124.3 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 13,684,753.00 | EPS (TTM) -3.07 | PE Ratio -2.90 | Exchange NCM |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 18 | 21 |
| Number of Buys | 18 | 18 |
| Number of Sells | 0 | 3 |
| Net Activity | 12743352 | 12727428 |
| Last 10 Buys | Shares |
|---|---|
| Peter Sonsini | 1,000 |
| Peter Sonsini | 1,000 |
| Ravi Viswanathan | 1,000 |
| Ravi Viswanathan | 1,000 |
| David M. Mott | 1,000 |
| David M. Mott | 1,000 |
| Sandell D Scott | 1,000 |
| Sandell D Scott | 1,000 |
| Anthony A. Florence | 1,000 |
| Anthony A. Florence | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| William R. Larue | 1,000 |
| Ronald L. Shazer | 1,000 |
| Charles P. Theuer | 1,000 |
| H Casey Logan | 1,000 |
| Charles P. Theuer | 1,000 |
| Charles P. Theuer | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 6 | 6 | 6 | 6 |
| Low Target Price Estimate | 5.5 | 5.5 | 5.5 | 5.5 |
| Mean Target Price Estimate | 5.75 | 5.75 | 5.75 | 5.75 |
| Standard Deviation | 0.35 | 0.35 | 0.35 | 0.35 |
| Date of Most Recent Estimate | 05/15/18 | 05/15/18 | 05/15/18 | 05/15/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-06-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-13 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-13 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-30 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-30 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2 | 2 | 1.67 | 1.67 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait 